Markets.com Logo

XPH

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    46.6075$
  • Previous Close
    47.1647$
  • 52 Week Change
    --
  • Day Range
    -0.56$
  • 52 Week High/Low
    --
  • Dividend Per Share
    --
  • Market cap
    --$
  • EPS
    --
  • Beta
    --
  • Volume
    --

About

XPH.US represents the SPDR S&P Pharmaceutical ETF, an exchange-traded fund that seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Pharmaceuticals Select Industry Index. This index tracks the performance of publicly traded pharmaceutical companies within the S&P Total Market Index, offering investors exposure to a focused segment of the healthcare sector. The fund generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index.

Gold's Safe-Haven Status Under Scrutiny: Market Dynamics and Price Outlook

Emma Rose|--

Trump's Iran War Exit Without a Deal: Reshaping Middle East Energy Security and Power Dynamics

Emma Rose|--
European market insights: What is the European stock market doing right now?

European market insights: What is the European stock market doing right now?

Ghko B|--
EUR/USD Analysis Today: EUR/USD Gains to 1.1550 as Middle East Uncertainty Lingers

EUR/USD Analysis Today: EUR/USD Gains to 1.1550 as Middle East Uncertainty Lingers

Ghko B|--

Microsoft at a Crossroads: AI Hurdles and Cloud Resilience Amidst Market Volatility

Sophia Claire|--

Iran's Hormuz Gambit: Leveraging a Chokepoint for Economic Leverage and Global Impact

Ava Grace|--

Gold Market Resilience: Navigating Sell-offs and Sustaining Bull Run

Noah Lee|--

Factors

[Pharmaceutical Sector Performance]: XPH's price heavily depends on the overall health and performance of the pharmaceutical industry.

[Economic Conditions]: Macroeconomic factors like interest rates, inflation, and GDP growth can influence investment in pharmaceutical stocks.

[Regulatory Changes]: Government regulations, drug approvals, and healthcare policies can significantly impact pharmaceutical company profits and thus XPH's value.

[Mergers and Acquisitions]: Major M&A activity within the pharmaceutical sector can cause volatility and price fluctuations in XPH.

[Clinical Trial Results]: Positive or negative results from clinical trials for new drugs can greatly influence individual pharmaceutical company stock prices within XPH.

[Patent Expirations]: Patent expirations of blockbuster drugs can negatively impact pharmaceutical company revenues and subsequently XPH's price.

[Competition]: Increased competition from generic drugs and biosimilars can put pressure on pharmaceutical company earnings and XPH's performance.

[Market Sentiment]: Overall investor sentiment towards the healthcare sector and risk appetite can affect demand for XPH and its price.

People Also Watch

Latest news

US Steel and Aluminum Tariffs Revamped: Simplification Amidst Potential Cost Increases

Noah Lee|--

SpaceX Files Secret IPO Bid, Eyeing Record-Breaking $1.75 Trillion Valuation

Ava Grace|--

US Intelligence: Iran Unwilling to Engage in Substantive Talks to End War

Sophia Claire|--

Latest Education Articles

What Is Sensex in Stock Market: Meaning, Calculation, and Why It Matters for Investors

What Is Sensex in Stock Market: Meaning, Calculation, and Why It Matters for Investors

Ghko B|--
Investing basics for beginners: What are the 4 economic indicators?

Investing basics for beginners: What are the 4 economic indicators?

Frances Wang|--
CFDs vs Options: What’s the Difference?

CFDs vs Options: What’s the Difference?

Julian Parker|--